SCHEMBL28297852

SCHEMBL28297852

CC(C)(C)OC(=O)N1CC[C@H](c2c(F)ccc(F)c2F)C1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TRPV3 Q8NET8 3/20 0.52
GPR119 Q8TDV5 6/20 0.50
PDE4B Q07343 1/20 0.48
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46
THRB P10828 1/20 0.46
NAMPT P43490 1/20 0.45
HPGDS O60760 1/20 0.44
POLB P06746 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
USP30 Q70CQ3 1/20 0.44
PTPN2 P17706 1/20 0.43
PTPN1 P18031 1/20 0.43
PTPN6 P29350 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28297774 0.88 KDM4E (0.50) TRPV3GPR119PDE4BKDM4EMAPT
SCHEMBL28297784 0.88 KDM4E (0.50) TRPV3GPR119PDE4BKDM4EMAPT
SCHEMBL19405061 0.88 GPR119 (0.52) TRPV3GPR119PDE4BKDM4EMAPT
SCHEMBL12883599 0.84 GPR119 (0.49) TRPV3GPR119KDM4EMAPTTHRB
SCHEMBL12883601 0.84 GPR119 (0.49) TRPV3GPR119KDM4EMAPTTHRB
SCHEMBL25042974 0.83 GPR119 (0.48) TRPV3GPR119PDE4BKDM4EMAPT
SCHEMBL25044017 0.82 PDE4B (0.54) TRPV3GPR119PDE4BMAPTHPGDS
SCHEMBL20438981 0.81 GPR119 (0.51) TRPV3GPR119KDM4EMAPTTHRB
SCHEMBL20439007 0.80 THRB (0.55) TRPV3GPR119KDM4EMAPTTHRB
SCHEMBL28812695 0.80 GPR119 (0.54) GPR119KDM4EMAPTTHRBNAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109715633-A Dopamine-B-hydroxylase inhibitors 巴尔-波特拉及康邦亚股份有限公司 2019-05-03 CN disclosed
CN-109715155-A blood brain barrier-penetrating agent dopamine- β -hydroxylase inhibitors 巴尔-波特拉及康邦亚股份有限公司 2019-05-03 CN disclosed